Akums Drugs & Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Akums Drugs & Pharma	Procter&Gamble Healt	Sanofi Cons. Health
Operational Metrics
Pharmaceuticals
DMF Filingsby API	20.0 .	n/a	n/a
R&D as a % of Total Sales	0.7 %	n/a	n/a
Financials
5 yr Average ROE	6.41 %	36.03 %	69.42 %
5yr average Equity Multiplier	3.41	1.79	1.86
5yr Average Asset Turnover Ratio	1.09	0.77	1.38
5yr Avg Net Profit Margin	1.94 %	19.19 %	27.33 %
Price to Book	3.25	21.72	27.4
P/E	42.21	34.85	40.8
5yr Avg Cash Conversion Cycle	35.36 Days	-155.74 Days	-89.93 Days
Inventory Days	61.49 Days	36.01 Days	38.19 Days
Days Receivable	65.6 Days	40.92 Days	8.58 Days
Days Payable	84.5 Days	215.28 Days	130.28 Days
5yr Average Interest Coverage Ratio	1.96	500.05	75.14
5yr Avg ROCE	5.99 %	30.21 %	83.24 %
5yr Avg Operating Profit Margin	6.33 %	27.53 %	37.31 %
5 yr average Debt to Equity	0.41	0.0	0.0
5yr CAGR Net Profit	n/a	4.02 %	7.8 %
5yr Average Return on Assets	1.61 %	15.5 %	37.82 %
Shareholdings
Promoter Holding	75.26 %	51.82 %	71.27 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	10.87 %
Change in Mutual Fund Holding (3 Yrs)	5.77 %	0.95 %	0.57 %

	Akums Drugs & Pharma	Procter&Gamble Healt	Sanofi Cons. Health
Product Wise Break-Up	Product Wise Break-Up CDMO 78.18 Branded and generic formulations 16.74 API 5.09 Consumer Healthcare Products 0	-	Product Wise Break-Up CDMO 0 Branded and generic formulations 0 API 0 Consumer Healthcare Product 100.0
Location Wise Break-Up	Location Wise Break-Up India 93.55 Outside India 6.45 International 0 Domestic 0	Location Wise Break-Up Domestic 93.19 India 0 International 6.81 Outside India 0	Location Wise Break-Up Domestic 0 India 81.38 International 0 Outside India 18.62
Operating Profit Break-Up	Operating Profit Break-Up CDMO 88.08 Branded and generic formulations 11.92 API`s 0	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise CDMO 76.41 API`s 14.71 Branded and generic formulations 8.88	-	-